Answers are grounded in this paper and cite their sources.
To the Editor: Medulloblastoma is one of the most common malignant brain tumors in children. The tumor is currently divided into four molecular and clinically distinct groups: wingless (WNT), sonic hedgehog (SHH), Group 3, and Group 4.1 These groups are recognized as important prognostic factors. MYC amplification is a poor prognostic factor in Group 3 medulloblastomas.2 Recently, subgrouping of Group 3/4 medulloblastomas has emerged as another potential prognostic biomarker.3 However, the clinical significance of this subgrouping is unclear when alterations are observed in different parts of the tumor tissue. Furthermore, the spatial heterogeneity of tumor molecular groups has not been extensively explored. We describe a case of a Group 3 medulloblastoma with a poor outcome that showed heterogeneity in both MYC amplification and molecular subtyping of the tumor. A 2-year-old girl with no prior medical or family history presented with vomiting and drowsiness. Neurological examination revealed disturbances in consciousness and gait ataxia. Contrast-enhanced brain MRI showed a heterogeneously enhancing tumor in the fourth ventricle, measuring up to 41 mm, accompanied by hydrocephalus (Figure 1A and B). There was no evidence of dissemination on cerebrospinal fluid cytology or spinal MRI. The patient underwent total tumor resection with an uneventful postoperative course except for reversible cerebellar mutism. Morphologically, the tumor consisted of clustered cells with two distinct appearances: one showed rod-shaped nuclei and Homer–Wright rosettes, consistent with classic medulloblastoma (Figure 2A and F), while the other showed more highly anaplastic cells with cell-wrapping features, suggesting a large cell/anaplastic (LC/A) subtype (Figure 2A and D). Mitoses and necrosis were observed in both areas. Immunohistochemically, the LC/A portion was positive for MYC, while the classic portion was negative. The MIB-1 index varied by pathological subtype, that is, it was as high as 45% in the LC/A region but 30% in the classic region (Figure 2B). Both regions were immunopositive for synaptophysin (not shown). Overall, the pathological diagnosis was LC/A medulloblastoma; however, approximately half of the tumor showed classic histology (Figure 2A).
No takes yet. Share an insight, caveat, or question.
Fukuoka et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: